Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf(Sahlgrenska University Hospital), Peter Sever(Imperial College London), Neil R Poulter(Imperial College London), Hans Wedel(Nordic School of Public Health), DG Beevers(Birmingham City Hospital), Mark J. Caulfield(Queen Mary University of London), Rory Collins(University of Oxford), Sverre E. Kjeldsen(Ullevål Sykehusapotek), Arni Kristinsson(Reykjavík University), Gordon T. McInnes(University of Glasgow), Jesper Mehlsen(Frederiksberg Hospital), Markku S. Nieminen(Helsinki University Hospital), Eoin OʼBrien(Beaumont Hospital), Jan Östergren(Karolinska University Hospital)
The Lancet
September 1, 2005
Cited by 2,917

Abstract


Related Papers

No related papers found

Powered by citation graph analysis